Skip to content

Study on intestinal mucosal immunity of IgA nephropathy

Study on intestinal mucosal immunity of IgA nephropathy

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027959
Enrollment
Unknown
Registered
2019-12-07
Start date
2019-12-13
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immunoglobulin A nephropathy

Interventions

experimental group:Colonoscopy

Sponsors

Shenzhen Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria for IgA nephropathy; (2) Aged >= 18 years and <= 70 years; (3) Voluntarily accept the test and sign the informed consent form. (4) Patients who have not used hormone immunosuppressive agents and probiotics for nearly one month.

Exclusion criteria

Exclusion criteria: (1) Acute or purulent inflammation of the anus, rectum, or colon; (2) Severe ascites, women of gestational age; (3) Acute severe ulcerative colitis and suspected toxic megacolon; (4) Chronic inflammation of the abdominal cavity to extensive adhesions in the abdominal cavity; (5) Bleeding disorders, severe cardiopulmonary insufficiency, and extreme debilitation; (6) Acute diffuse peritonitis; (7) Patients with stage 4 and 5 of chronic kidney disease; (8) Patients with organ failure; (9) Other patients who are not suitable for colonoscopy due to their condition.

Design outcomes

Primary

MeasureTime frame
CD20;CD27;KM55;

Countries

China

Contacts

Public ContactYoujia Zeng

Shenzhen Hospital of Traditional Chinese Medicine

kangyuqi0203@163.com+86 0755-82732304

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026